Excelra, a global leader in life science data and digital solutions, has acquired BISC Global, a bioinformatics and data analytics consulting company with offices in Europe and the USA. This strategic move has created an international powerhouse in consulting-led bioinformatics, including expertise in artificial intelligence, machine learning, and omics and next-generation sequencing data analysis. Excelra already serves the world’s top pharmaceutical and biotechnology firms, providing data, insight, and R&D technology services. Through this deal, the company further strengthens its position as a leader in bioinformatics and analytics in the life sciences field.
BISC Global is an acclaimed provider of bioinformatics, biostatistics, artificial intelligence, and machine learning services. Its suite of services includes data analysis, pipeline development, cloud computing, data visualization, and more. Its flagship platforms, such as the Online Pipeline Platform (OP2), and ImmunoRaptor, make it easy for researchers to manage and analyze next-generation sequencing data.
Maarten Braspenning, CEO of BISC Global, believes the acquisition will create greater synergy between the two firms, thus enabling them to offer best-in-class bioinformatics services. For his part, Excelra CEO Anandbir Singh Brar sees the deal as an opportunity to expand their capabilities and make a positive impact on the future of bioinformatics and the life science industry.
This acquisition creates an international powerhouse in bioinformatics and analytics, allowing Excelra to deliver integrated solutions to its customers at an unparalleled scale. With a wide range of platforms and services, Excelra will now be able to drive greater innovation in the life sciences field and extract essential insights from large volumes of data.
